Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors

    Inhibition of mutant KRAS challenged cancer research for decades. Recently, allele-specific inhibitors were approved for the treatment of KRAS-G12C mutant lung cancer. However, de novo and acquired resistance lim...

    Marcell Baranyi, Eszter Molnár, Luca Hegedűs, Zsófia Gábriel in British Journal of Cancer (2024)

  2. Article

    Open Access

    Comparison of standard mismatch repair deficiency and microsatellite instability tests in a large cancer series

    The tumor-agnostic indication of immune checkpoint inhibitors to treat cancers with mismatch repair deficiency (dMMR)/microsatellite instability (MSI) increased the demand for such tests beyond Lynch syndrome....

    Maja L. Nádorvári, István Kenessey, András Kiss in Journal of Translational Medicine (2024)

  3. Article

    Open Access

    Newly identified form of phenotypic plasticity of cancer: immunogenic mimicry

    Cancer plasticity is now a recognized new hallmark of cancer which is due to disturbances of cell differentiation programs. It is manifested not only in various forms like the best-known epithelial-mesenchymal...

    József Tímár, Kenneth V. Honn, Mary J. C. Hendrix in Cancer and Metastasis Reviews (2023)

  4. Article

    Open Access

    A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures

    PARP inhibitors are approved for the treatment of solid tumor types that frequently harbor alterations in the key homologous recombination (HR) genes, BRCA1/2. Other tumor types, such as lung cancer, may also be ...

    Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok in npj Precision Oncology (2021)

  5. Article

    Guest editorial/preface

    József Tímár in Cancer and Metastasis Reviews (2020)

  6. Article

    Open Access

    Molecular epidemiology and diagnostics of KRAS mutations in human cancer

    RAS mutation is the most frequent oncogenic alteration in human cancers. KRAS is the most frequently mutated followed by NRAS. The emblematic KRAS mutant cancers are pancreatic, colorectal, lung adenocarcinoma...

    Jozsef Timar, Karl Kashofer in Cancer and Metastasis Reviews (2020)

  7. Article

    Open Access

    Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis

    Langerhans cell histiocytosis (LCH) is characterized by mutations of the RAS-RAF-MAPK signaling pathway. We analyzed MAP2K1, NRAS and KIT mutation incidence in skin lesions of BRAF wild-type (wt) LCH patients....

    Béla Tóth, Norbert Kiss, Judit Hársing, Sarolta Kárpáti, Judit Csomor in Virchows Archiv (2020)

  8. Article

    Open Access

    Prevalence of APC and PTEN Alterations in Urachal Cancer

    Urachal carcinoma (UrC) is a rare tumor with remarkable histological and molecular similarities to colorectal cancer (CRC). Adenomatous polyposis coli (APC) is the most frequently affected gene in CRC, but the pr...

    Nikolett Nagy, Henning Reis, Boris Hadaschik in Pathology & Oncology Research (2020)

  9. No Access

    Article

    EGFR Protein Expression of KRAS Wild-Type Colorectal Cancer: Predictive Value of the Sidedness for Efficacy of Anti-EGFR Therapy

    Right- and left-sided colorectal cancers (RSCRC and LSCRC, respectively) are different developmentally, genetically and prognostically. Clinical data also indicate that they respond differently to anti-EGFR th...

    A. Uhlyarik, V. Piurko, L. Vizkeleti, Zs Pápai, E. Rásó in Pathology & Oncology Research (2020)

  10. No Access

    Article

    Next Generation Lipophilic Bisphosphonate Shows Antitumor Effect in Colorectal Cancer In Vitro and In Vivo

    Bisphosphonates, despite proven antitumor effect in vitro in many tumor types, are currently used only for treatment of osteoporosis and bone metastasis. Colorectal cancer is the third most commonly diagnosed ...

    Marcell Baranyi, Dominika Rittler, Eszter Molnár in Pathology & Oncology Research (2020)

  11. No Access

    Article

    Selective Inhibition of HIF1α Expression by ZnSO4 Has Antitumoral Effects in Human Melanoma

    Zinc as an essential trace metal is a ubiquitous component of various molecules of the cell. Studies indicated that it may modulate functions of various cancer cell types, and can even inhibit metastasis forma...

    Z. Burián, A. Ladányi, T. Barbai, V. Piurkó, T. Garay in Pathology & Oncology Research (2020)

  12. Article

    Open Access

    KIT Mutation Incidence and Pattern of Melanoma in Central Europe

    Data on the KIT mutation rate in melanoma in the central European region is missing. Accordingly, in a cohort of 79 BRAF/NRAS double wild type cutaneous melanoma and 17 mucosal melanoma KIT mutation was assess...

    V. Doma, T. Barbai, M.-A. Beleaua, I. Kovalszky, E. Rásó in Pathology & Oncology Research (2020)

  13. No Access

    Article

    Aquaporin-1 Protein Expression of the Primary Tumor May Predict Cerebral Progression of Cutaneous Melanoma

    Brain metastasis is a frequent complication of the progression of malignant melanoma. In a previous study aquaporin 1 (AQP1) protein expression was found to be associated with increased mortality and decreased...

    E. Imrédi, G. Liszkay, I. Kenessey, V. Plotár, M. Gödény in Pathology & Oncology Research (2020)

  14. Article

    Open Access

    Clinical protein science in translational medicine targeting malignant melanoma

    Melanoma of the skin is the sixth most common type of cancer in Europe and accounts for 3.4% of all diagnosed cancers. More alarming is the degree of recurrence that occurs with approximately 20% of patients l...

    Jeovanis Gil, Lazaro Hiram Betancourt, Indira Pla in Cell Biology and Toxicology (2019)

  15. Article

    Open Access

    Expression of calcium pumps is differentially regulated by histone deacetylase inhibitors and estrogen receptor alpha in breast cancer cells

    Remodeling of Ca2+ signaling is an important step in cancer progression, and altered expression of members of the Ca2+ signaling toolkit including the plasma membrane Ca2+ ATPases (PMCA proteins encoded by ATP2B ...

    Karolina Varga, Anna Hollósi, Katalin Pászty, Luca Hegedűs, Gergely Szakács in BMC Cancer (2018)

  16. No Access

    Article

    The role of lipid signaling in the progression of malignant melanoma

    In the past decades, a vast amount of data accumulated on the role of lipid signaling pathways in the progression of malignant melanoma, the most metastatic/aggressive human cancer type. Genomic studies identi...

    József Tímár, B. Hegedüs, E. Rásó in Cancer and Metastasis Reviews (2018)

  17. No Access

    Article

    Chemotherapy treatment is associated with altered PD-L1 expression in lung cancer patients

    While the predictive value of programmed cell death ligand-1 (PD-L1) protein expression for immune checkpoint inhibitor therapy of lung cancer has been extensively studied, the impact of standard platinum-base...

    Lívia Rojkó, Lilla Reiniger, Vanda Téglási in Journal of Cancer Research and Clinical On… (2018)

  18. Article

    Open Access

    Pan-RAF and MEK vertical inhibition enhances therapeutic response in non-V600 BRAF mutant cells

    Currently, there are no available targeted therapy options for non-V600 BRAF mutated tumors. The aim of this study was to investigate the effects of RAF and MEK concurrent inhibition on tumor growth, migration...

    Eszter Molnár, Dominika Rittler, Marcell Baranyi, Michael Grusch in BMC Cancer (2018)

  19. Article

    Open Access

    NSCLC molecular testing in Central and Eastern European countries

    The introduction of targeted treatments for subsets of non-small cell lung cancer (NSCLC) has highlighted the importance of accurate molecular diagnosis to determine if an actionable genetic alteration is pres...

    Ales Ryska, Peter Berzinec, Luka Brcic, Tanja Cufer, Rafal Dziadziuszko in BMC Cancer (2018)

  20. No Access

    Article

    p16INK4 expression is of prognostic and predictive value in oropharyngeal cancers independent of human papillomavirus status: a Hungarian study

    Head and neck cancer treatment protocols still lack well-established biomarkers of prognostic and predictive value. It is well known that human papillomavirus (HPV)-related and non-HPV-related oropharyngeal ca...

    Diana Brauswetter, Ede Birtalan, Kornel Danos in European Archives of Oto-Rhino-Laryngology (2017)

previous disabled Page of 4